INT54167

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.42
First Reported 1993
Last Reported 2008
Negated 0
Speculated 0
Reported most in Abstract
Documents 4
Total Number 4
Disease Relevance 1.26
Pain Relevance 0.63

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

extracellular region (NPPA) nucleus (NPPA) cytoplasm (NPPA)
Anatomy Link Frequency
plasma 4
NPPA (Homo sapiens)
Pain Link Frequency Relevance Heat
Dynorphin 1 91.08 High High
Clonidine 4 87.04 High High
Pain 1 85.92 High High
Neuropeptide 1 82.56 Quite High
headache 2 69.20 Quite High
cva 1 63.44 Quite High
Catecholamine 3 54.32 Quite High
vincristine 2 5.00 Very Low Very Low Very Low
imagery 2 5.00 Very Low Very Low Very Low
antagonist 2 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Natriuresis 7 100.00 Very High Very High Very High
Body Weight 1 100.00 Very High Very High Very High
Cardiovascular Disorder Under Development 17 94.52 High High
Apoptosis 5 87.48 High High
Hypertension 4 86.08 High High
Pressure And Volume Under Development 3 78.04 Quite High
Injury 1 73.68 Quite High
Headache 1 69.20 Quite High
Hemorrhage 1 63.44 Quite High
Stress 3 52.56 Quite High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
The magnitudes of increased ANF and decreased Vas were correlated with the decreased MBP (r = -0.57 and 0.53, respectively, P < 0.05).
Negative_regulation (decreased) of Positive_regulation (increased) of ANF
1) Confidence 0.42 Published 1993 Journal Zhongguo Yao Li Xue Bao Section Abstract Doc Link 7901963 Disease Relevance 0.25 Pain Relevance 0.42
Over the 0-24 h time period following GW660511X 200 mg, there were significant (P<0.001) reductions in serum ACE activity and significant (P<0.001) increases in plasma ANP concentration compared with placebo in terms of both peak and trough effects.
Negative_regulation (reductions) of Positive_regulation (increases) of ANP in plasma
2) Confidence 0.42 Published 2006 Journal J Hum Hypertens Section Abstract Doc Link 16543907 Disease Relevance 0.21 Pain Relevance 0.07
When all courses were taken together, an increase in ANP and CK-MB occurred after DXR.
Negative_regulation (occurred) of Positive_regulation (increase) of ANP
3) Confidence 0.24 Published 2008 Journal J Cancer Res Clin Oncol Section Body Doc Link PMC2515587 Disease Relevance 0.31 Pain Relevance 0.03
Spironolactone induced a significant reduction of plasma volume (42.1 +/- 5.5 to 36.1 +/- 6.6 mL/kg body weight, P < .01) and of the concentration of alpha-atrial natriuretic peptide (alpha-ANP) (39.8 +/- 22 to 27.7 +/- 20 pg/mL, P < .01); in addition, a pronounced increase in plasma renin activity (PRA) (1.1 +/- 0.9 to 7.5 +/- 3.4 ng/mL/h, P < .001) was induced by the treatment.
Negative_regulation (reduction) of Positive_regulation (induced) of natriuretic peptide in plasma associated with natriuresis and body weight
4) Confidence 0.06 Published 1996 Journal Hepatology Section Abstract Doc Link 8621132 Disease Relevance 0.49 Pain Relevance 0.12

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox